MDXG
MiMedx Group, Inc.
MDXG trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MDXG overall, supported by stronger fundamentals and stronger modeled upside.
MDXG Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Stable | |
| Strong |
MDXG's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MDXG PE Valuation
MDXG has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MDXG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MDXG's earnings to grow and its profitability to improve, but its revenue to decline.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over MDXG on the outlook, with more favorable revenue expectations.
MDXG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.07 | — |
| Q3 2026 | -$0.13 | -148% |
| Q2 2026 | $0.04 | -81% |
| Q1 2026 | $0.20 | -26% |
| Q4 2025 | $0.32 | +14% |
| Q3 2025 | $0.27 | -55% |
| Q2 2025 | $0.21 | -66% |
| Q1 2025 | $0.27 | -45% |
| Q4 2024 | $0.28 | -24% |
MDXG has swung to a loss: it lost $0.13 per share over the past year, after a profit the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MDXG on earnings quality, reporting a profit while its opponent remains loss making.
MDXG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $62.3M | -45% |
| Q2 2026 | $64.4M | -35% |
| Q1 2026 | $59M | -33% |
| Q4 2025 | $118.1M | +27% |
| Q3 2025 | $113.7M | +35% |
| Q2 2025 | $98.6M | +13% |
| Q1 2025 | $88.2M | +4.1% |
| Q4 2024 | $92.9M | +7% |
MDXG's revenue is shrinking: $62M last quarter, down 45% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -19% | -38 points |
| Q2 2026 | -29% | -41 points |
| Q1 2026 | -27% | -37 points |
| Q4 2025 | 18% | +6 points |
| Q3 2025 | 20% | +6.2 points |
| Q2 2025 | 13% | -14 points |
| Q1 2025 | 9.3% | -6.2 points |
| Q4 2024 | 12% | -19 points |
MDXG's operating margin was −19% last quarter, down 38 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over MDXG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MDXG on profitability, with a higher operating margin.
MDXG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9M | -87% |
| Q2 2026 | -$10M | -169% |
| Q1 2026 | $1.9M | -65% |
| Q4 2025 | $25M | +33% |
| Q3 2025 | $29.3M | +49% |
| Q2 2025 | $14.4M | -34% |
| Q1 2025 | $5.3M | -11% |
| Q4 2024 | $18.8M | +91% |
MDXG generated $21M in free cash flow over the past year, down 69% from the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MDXG on cash flow, with more consistent year-over-year improvement.
MDXG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -1.9M shares |
| 1 year | -2.6% | -3.8M shares |
| 3 years | +22% | +26.5M shares |
| 5 years | +32% | +35.1M shares |
| Available history | +36% | +38.9M shares |
MDXG has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $304,000 |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MDXG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -10.1x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -1.4x | Net Cash |
| Q3 2024 | -0.9x | Net Cash |
MDXG has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MDXG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 15.2 | Oversold |
MDXG's weekly RSI is 28 (oversold) and its Stochastic is 15 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MDXG PE vs Healthcare Sector
| Metric | MDXG | Sector median | Relative |
|---|---|---|---|
| PE | 98x | 26x | 278% above |
| PE % | 92 | 29 | 63 pts above |
MDXG has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over MDXG on valuation relative to its sector.
MDXG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.09 | 21% below |
| 20 week MA | $4.24 | 24% below |
| 50 week MA | $4.52 | 28% below |
| 100 week MA | $5.92 | 45% below |
| 200 week MA | $6.31 | 49% below |
MDXG is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MDXG on trend strength, trading above more of its moving averages.
MDXG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.25 | $9.40 | +30% |
| 2021 | $9.40 | $6.49 | -31% |
| 2022 | $6.49 | $2.77 | -57% |
| 2023 | $2.77 | $8.77 | +217% |
| 2024 | $8.77 | $9.42 | +7.4% |
| 2025 | $9.42 | $6.90 | -27% |
| 2026 YTD | $6.90 | $3.24 | -53% |
MDXG's yearly returns have swung widely, from +217% in 2023 to −57% in 2022. It's down 53% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MDXG on returns for 2026, with the stronger performance.